SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
Selected A-share Announcements | Star companies such as PetroChina (601857.SH) and Tianshan Aluminum Group (002532.SZ) have released their financial reports intensively.
New Stock News | Sinopec New Energy to hold a hearing at the Hong Kong Stock Exchange, with revenue expected to increase almost sevenfold year-on-year by 2025.
INSILICO (03696) released its financial report, adding over 10 collaborations and holding $393 million in cash.
Selected A-share Announcements | Star companies such as PetroChina (601857.SH) and Tianshan Aluminum Group (002532.SZ) have released their financial reports intensively.
New Stock News | Sinopec New Energy to hold a hearing at the Hong Kong Stock Exchange, with revenue expected to increase almost sevenfold year-on-year by 2025.
INSILICO (03696) released its financial report, adding over 10 collaborations and holding $393 million in cash.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
